NCT06376149 M3-JIA: Making Mindfulness Matter for Children With JIA
| NCT ID | NCT06376149 |
| Status | Recruiting |
| Phase | — |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Condition | Juvenile Idiopathic Arthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 74 participants |
| Start Date | 2024-09-12 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 74 participants in total. It began in 2024-09-12 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigator will evaluate the efficacy of M3©, an intervention for patients with JIA and their caregivers. Children with Juvenile arthritis and their parents will attend an 8 week online program called Making Mindfulness Matter (M3). This is a facilitator-led program that integrates knowledge and skills related to mindfulness, social-emotional learning, neuroscience, and positive psychology to promote coping and resiliency for children and families in context of the challenges of pediatric chronic disease. The child program is designed for children 4-12 years of age, with each lesson including a variety of concrete ways to teach children skills based on their age/developmental level.
Eligibility Criteria
Inclusion Criteria: * Children aged 4 to 12 years diagnosed with JIA * Children have reasonable comprehension of spoken language and can follow simple instructions * Children with JIA and their caregivers are willing to attend intervention sessions and have access to technology and internet to attend the online sessions. * Children with JIA and their caregivers have an adequate understanding of English Exclusion Criteria: * Other major co-morbid disorders (e.g. Crohn's disease, diabetes, renal failure). * Concurrent enrollment in other intervention trials or practicing any complementary health interventions such as yoga, meditation, or daily mindfulness practice.
Contact & Investigator
Roberta Berard, MD
PRINCIPAL INVESTIGATOR
LHSC Children's Hospital/ Lawson Research
Frequently Asked Questions
Who can join the NCT06376149 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 12 Years, studying Juvenile Idiopathic Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06376149 currently recruiting?
Yes, NCT06376149 is actively recruiting participants. Contact the research team at sarah.wells@lhsc.on.ca for enrollment information.
Where is the NCT06376149 trial being conducted?
This trial is being conducted at Hamilton, Canada, London, Canada, Toronto, Canada.
Who is sponsoring the NCT06376149 clinical trial?
NCT06376149 is sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. The principal investigator is Roberta Berard, MD at LHSC Children's Hospital/ Lawson Research. The trial plans to enroll 74 participants.